Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Synagis Prescribers

December 11, 2006
Numax is effective, but at what price?
By a GLG Expert Contributor
Analysis of: Numax(R) Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis(R) (biz.yahoo.com)
-Numax, if approved, is certain to be more expensive than its parent compound Synagis.-Synagis already works extremely well and is extremely expensive. The only reason for development of Numax is patent protection and higher margin. This may be a reason in and of itself for the FDA to decline to approve...
November 1, 2006
Merck's Prevnar (pneumococcal vaccine) works too well
By a GLG Expert Contributor
Analysis of: Pneumococcal Disease Vaccine (www.medicalnewstoday.com)
-Merck's Prevnar (strep pneumoniae) vaccine is approved in the US as a 4-dose schedule-This article in the Lancet found that 2 or 3 doses worked about as well as the 4-dose schedule currently approved in the US-This may allow expansion of use outside of the usual 1st world but is unlikely to cause a...
November 1, 2006
Gardasil's European Vacation
By a GLG Expert Contributor
Analysis of: Sanofi Pasteur Begins Selling Merck's HPV Vaccine Gardasil In Six E.U. Countries (www.medicalnewstoday.com)
-The EU has approved Merck's Gardsail for use in Europe to prevent cervical cancer-Merck has partnered with Sanofi to sell Gardasil in 6 European countries to start-Besides being a public health boon, the partnership will benefit both Merck and it's Europe-savvy partner, Sanofi-Aventis

Previous Page : 1 2 3 4 5 651 to 53 of 53

Analytics


Generated at 2009-01-09T13:00:20.343